FI960748A - Antipsykotiskt förfarande - Google Patents

Antipsykotiskt förfarande Download PDF

Info

Publication number
FI960748A
FI960748A FI960748A FI960748A FI960748A FI 960748 A FI960748 A FI 960748A FI 960748 A FI960748 A FI 960748A FI 960748 A FI960748 A FI 960748A FI 960748 A FI960748 A FI 960748A
Authority
FI
Finland
Prior art keywords
antipsychotic method
antipsychotic
schizophrenia
susceptible
treating
Prior art date
Application number
FI960748A
Other languages
English (en)
Finnish (fi)
Other versions
FI960748A0 (sv
Inventor
Franklin Porter Bymaster
Harlan E Shannon
Per Sauerberg
Preben H Olesen
John Stanley Ward
Charles H Mitch
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI960748A0 publication Critical patent/FI960748A0/sv
Publication of FI960748A publication Critical patent/FI960748A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Cosmetics (AREA)
  • Epoxy Resins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FI960748A 1993-08-19 1996-02-19 Antipsykotiskt förfarande FI960748A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10928593A 1993-08-19 1993-08-19
PCT/DK1994/000309 WO1995005379A1 (en) 1993-08-19 1994-08-18 Antipsychotic method

Publications (2)

Publication Number Publication Date
FI960748A0 FI960748A0 (sv) 1996-02-19
FI960748A true FI960748A (sv) 1996-04-18

Family

ID=22326851

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960748A FI960748A (sv) 1993-08-19 1996-02-19 Antipsykotiskt förfarande

Country Status (23)

Country Link
US (3) US5677313A (sv)
EP (1) EP0714394B1 (sv)
JP (1) JP3474575B2 (sv)
KR (1) KR960703908A (sv)
CN (1) CN1040979C (sv)
AT (1) ATE202353T1 (sv)
CA (1) CA2169838C (sv)
CZ (1) CZ42796A3 (sv)
DE (1) DE69427537T2 (sv)
DK (1) DK0714394T3 (sv)
ES (1) ES2160127T3 (sv)
FI (1) FI960748A (sv)
GR (1) GR3036587T3 (sv)
HU (1) HU222116B1 (sv)
IL (1) IL110727A (sv)
NO (1) NO310597B1 (sv)
NZ (2) NZ271313A (sv)
PT (1) PT714394E (sv)
SG (1) SG55072A1 (sv)
TW (1) TW442285B (sv)
UA (1) UA43347C2 (sv)
WO (1) WO1995005379A1 (sv)
ZA (1) ZA946321B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160127T3 (es) * 1993-08-19 2001-11-01 Novo Nordisk As Metodo antipsicotico con derivados de tiadiazol y oxadiazol.
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5821370A (en) * 1994-10-24 1998-10-13 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5726193A (en) * 1994-10-31 1998-03-10 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
PE17897A1 (es) * 1995-02-17 1997-06-12 Lilly Co Eli Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano
US5763457A (en) * 1995-11-13 1998-06-09 Eli Lilly And Company Method for treating anxiety
US5852037A (en) * 1995-11-13 1998-12-22 Eli Lilly And Company Method for treating anxiety
US5998434A (en) * 1995-12-06 1999-12-07 Eli Lilly And Company Composition for treating pain
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
AU7107998A (en) * 1997-04-11 1998-11-11 Eli Lilly And Company Method for treating schizophrenia
JP2002503224A (ja) * 1997-04-11 2002-01-29 エリ リリー アンド カンパニー 疼痛を処置するための組成物
US20040023951A1 (en) * 2001-06-18 2004-02-05 Bymaster Franklin Porter Combination therapy for treatment of psychoses
AU2008326360A1 (en) * 2007-11-21 2009-05-28 Abbott Laboratories Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators
JP2011520905A (ja) 2008-05-15 2011-07-21 ザ・ユニバーシティ・オブ・トレド 向知性剤としてのムスカリンアゴニスト
US9549928B2 (en) 2011-04-29 2017-01-24 The University Of Toledo Muscarinic agonists as enhancers of cognitive flexibility

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789039T2 (de) * 1986-06-27 1994-06-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen.
US4977176A (en) * 1987-01-31 1990-12-11 Sandoz Ltd. Pilocarpine compounds which are used as pharmaceutical agents
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
ES2160127T3 (es) * 1993-08-19 2001-11-01 Novo Nordisk As Metodo antipsicotico con derivados de tiadiazol y oxadiazol.

Also Published As

Publication number Publication date
NO960620L (no) 1996-04-18
DK0714394T3 (da) 2001-10-01
US5968926A (en) 1999-10-19
CA2169838A1 (en) 1995-02-23
AU697529B2 (en) 1998-10-08
CN1040979C (zh) 1998-12-02
JP3474575B2 (ja) 2003-12-08
DE69427537T2 (de) 2002-04-04
CZ42796A3 (en) 1996-12-11
PT714394E (pt) 2001-12-28
WO1995005379A1 (en) 1995-02-23
NZ271313A (en) 1999-09-29
NO960620D0 (no) 1996-02-16
ZA946321B (en) 1996-02-19
CN1133044A (zh) 1996-10-09
HUT73854A (en) 1996-09-30
DE69427537D1 (de) 2001-07-26
ATE202353T1 (de) 2001-07-15
NO310597B1 (no) 2001-07-30
AU7490494A (en) 1995-03-14
NZ336596A (en) 2001-02-23
SG55072A1 (en) 1998-12-21
KR960703908A (ko) 1996-08-31
HU9600363D0 (en) 1996-04-29
IL110727A0 (en) 1994-11-11
HU222116B1 (hu) 2003-04-28
US5677313A (en) 1997-10-14
TW442285B (en) 2001-06-23
FI960748A0 (sv) 1996-02-19
JPH09501659A (ja) 1997-02-18
US5679686A (en) 1997-10-21
ES2160127T3 (es) 2001-11-01
CA2169838C (en) 2002-06-11
GR3036587T3 (en) 2001-12-31
IL110727A (en) 1998-08-16
UA43347C2 (uk) 2001-12-17
EP0714394A1 (en) 1996-06-05
EP0714394B1 (en) 2001-06-20

Similar Documents

Publication Publication Date Title
DK0714394T3 (da) Antipsykotisk fremgangsmåde
DE69433394D1 (de) Botulinustoxine zur Modulation cholinergisch-kontrollierter Sekretionen
FI20050461A (sv) Antipsykotiskt förfarande
DE69421296D1 (de) Schmelzbehandlung
NO944040D0 (no) Induktivt ladeapparat
DE69401817D1 (de) Verbesserungen zum herstellen von glasartigem silika
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
NO953443D0 (no) Fremgangsmåte for behandling av fast avfall
NO942906L (no) Fremgangsmåte for oksydasjon av natriumsulfid
DE69324427D1 (de) Neues endbehandlungsverfahren für hydroxyfunktionelle polythethern
ES2135477T3 (es) Proceso de produccion de (s)-3-amino-1-pirrolidinas sustituidas.
NO941655D0 (no) Fremgangsmåte for detektering av sulfider
NO990450D0 (no) Behandling av sinnslidelser
DE69419598D1 (de) Abstichverfahren für hochofen
FI933624A0 (fi) Apparat foer pappers- och kartongmaskin samt dess anvaendning
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.
ITTO930166A1 (it) Procedimento per il trattamento di flussi reflui della produzione di n-fosfonometilglicina.
KR970004363U (ko) 협잡물 처리용 원심분리기
BR9304842A (pt) Processo de produção de ferro-gusa
FI931153A0 (fi) Anordning foer uppvaermning av stenmaterial
FIU930197U0 (fi) Apparat foer slipning av skridskor
SE9304270D0 (sv) Process II
KR950009954U (ko) 브라운관 재생용 어닐링로
KR960024336U (ko) 유리제 난시용 안경렌즈